Chia Tai Enterprises International Ltd

03839

Company Profile

  • Business description

    Chia Tai Enterprises International Ltd is engaged in the manufacture and sale of chlortetracycline (CTC) and animal health products. The company's operating segments include Biochemical operations and Industrial operations. It generates maximum revenue from the Biochemical operations segment, which is engaged in the manufacture and sale of chlortetracycline and animal health products. The Industrial segment is into the trading of machinery and the manufacture and sale of automotive parts through the group's joint ventures and associates. Its geographical segments are Mainland China, which generates key revenue, Asia Pacific (excluding mainland China), the Americas, Europe, and Others.

  • Contact

    16 Harcourt Road
    21st Floor, Far East Finance Centre
    Hong Kong
    HKG

    T: +852 25201601

    http://www.ctei.com.hk

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    900

Stocks News & Analysis

stocks

Undervalued ASX share searches for cost savings

Cost savings from recent acquisition underpin our earnings growth forecasts.
stocks

Chart of the Week: Where we see opportunities after year end market sell-off

The latest insights from our equity research team.
stocks

Solving the Australian equities conundrum

Where to look in a heavily concentrated index.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,868.2033.10-0.37%
CAC 408,022.6929.82-0.37%
DAX 4024,130.1432.51-0.13%
Dow JONES (US)48,057.75497.461.05%
FTSE 1009,655.5313.520.14%
HKSE25,540.78106.550.42%
NASDAQ23,654.1577.670.33%
Nikkei 22550,602.8052.30-0.10%
NZX 50 Index13,403.6832.620.24%
S&P 5006,886.6846.170.67%
S&P/ASX 2008,579.4031.70-0.37%
SSE Composite Index3,900.509.03-0.23%

Market Movers